SLNO
NASDAQ
$53.01
Soleno Therapeutics Inc (SLNO)
Sector:
Healthcare
Industry:
Biotechnology
Market Cap
$2.74B
Profit Margin
33.2%
Forward P/E
13.12
P/E Ratio
29.02
Price Chart
Valuation
Market Cap$2.74B
P/E29.02
Forward P/E13.12
Profitability
Total Revenue (TTM)$285M
Gross Profit (TTM)$281M
EBITDA$88M
Profit Margin33.2%
Operating Margin33.1%
EPS$1.83
Financial Health
Debt-to-Equity10.1%
Free Cash Flow Yield3.85%
Growth & Risk
Sharpe Ratio-0.21